| # | Drug | Count |
|---|---|---|
| 0 | FLUOROURACIL | 6 |
| 1 | FLUOROURACIL CREAM, 0.5% | 6 |
| 2 | OXALIPLATIN | 6 |
| 3 | LEUCOVORIN CALCIUM | 5 |
| 4 | OMEPRAZOLE | 5 |
| 5 | OMEPRAZOLE MAGNESIUM | 5 |
| 6 | APIXABAN | 4 |
| 7 | LOSARTAN | 4 |
| 8 | SIMVASTATIN | 4 |
| 9 | BECLOMETHASONE DIPROPIONATE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BECLOMETHASONE DIPROPIONATE | 3 | 0.0005 |
| 1 | LEUCOVORIN CALCIUM | 5 | 0.0003 |
| 2 | TREMELIMUMAB | 1 | 0.0002 |
| 3 | FELODIPINE | 1 | 0.0001 |
| 4 | OXALIPLATIN | 6 | 0.0001 |
| 5 | FLUOROURACIL CREAM, 0.5% | 6 | 0.0001 |
| 6 | FLUOROURACIL | 6 | 0.0001 |
| 7 | APIXABAN | 4 | 0.0001 |
| 8 | HUMAN IMMUNOGLOBULIN G | 1 | 0.0000 |
| 9 | DURVALUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 1 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 2 | Integrin Receptor Antagonist [EPC] | 3 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 6 | 0.0000 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 6 | 0.0000 |
| 5 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 6 | Purine Antimetabolite [EPC] | 2 | 0.0000 |
| 7 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 2 | 0.0000 |
| 9 | Factor Xa Inhibitor [EPC] | 4 | 0.0000 |